Abstract Body

Background

HIV preexposure prophylaxis (PrEP) with fixed-dose tenofovir disoproxil fumarate (TDF) and emtricitabine has been associated with relatively low rates of renal impairment in clinical trials, and renal toxicity has been considered less frequent than that observed in people living with HIV (PLWH). 

Methods

In a matched-cohort study, both TDF-treated PLWH and those receiving TDF-based PrEP were matched according to age, sex, serum creatinine, and lack of comorbidities (absence of hypertension, diabetes). The primary outcome was renal impairment, defined as a decrease in estimated glomerular filtration rate (eGFR), an eGFR <60 ml/min per 1.73 m2 (chronic kidney disease -CKD-), or data of proximal tubular renal toxicity (phosphaturia, proteinuria, glycosuria) at 12 months of follow up. The DAD renal risk score (DADr) was used to identify those participants at the highest risk of renal impairment in both cohorts.

Results

A total of 50 individuals receiving PrEP and 50 matched PLWH were selected. Median age was 36.3 years, all were male, and baseline serum creatinine was 0.92 mg/dL (eGFR of 102 ml/min), without initial cases of chronic kidney disease (CKD). DADr score was -2.4 and -1.8 in PLWH and PrEP users respectively. After 12 months, there was an eGFR decrease slightly higher in PrEP recipients (-5.95 vs -3.05 ml/min), whereas changes in tubular parameters were mainly observed in PLWH (TRP, tubular reabsorption of phosphate, -2.1% vs -1%; protein-to-creatinine ratio, +60.1 vs +40.8 mg/g creatinine). There was a significant correlation between DADr at baseline and changes in renal function during follow up, that againg was higher for PREP (serum creatinine and DADr, r=0.588; p=0.006; eGFR and DADr, r=-0.749; p<0.001) than that observed in PLWH (r=0.553; p=0.01; r=-0.631; p<0.01). Of note, the rate of CKD at 12 months was 4% and 3% in PREP and PLWH, but phosphaturia was observed in 18% receiving PrEP in comparison with 56% of PLWH.

Conclusions

In this matched-cohort study, we showed that TDF-containing PrEP was associated with a similar rate of early renal impairment in comparison with PLWH, despite a lower tubular renal involvement, in this cohort of otherwise healthy people receiving PrEP. The use of DAD renal risk score could help to identify those in higher risk of renal toxicity even in PrEP recipients.